A new treatment for liver cancer involving the removal of less than one lobe has been associated with lower mortality and overall fewer complications, an article in press published in the Journal of the American College of Surgeons finds.
Lung cancer is amongst one of the most common forms of cancer across the world and across genders. A new study hopes to show that nanoparticles could be used in the future to treat lung cancers more successfully than existing treatments.
A study reveals that approximately 19% of women in the UK diagnosed with breast cancer via mammogram were overdiagnosed (i.e. they were in no actual danger). However, some estimates go as far as to state 50% of women are overdiagnosed with breast cancer.
A new study into the disruption occurring in chromosomes in pancreatic cancer indicates that there are four subtypes of pancreatic cancer, depending on the level of disruption.
Scientists at Yale University have stated that exposure to sunlight continues to damage skin and increase the risk of skin cancer long after exposure has stopped.
Scientists at the University of Iowa believe they have developed a new exercise methodology that reduces efficiency in muscles and leads to greater calorie expenditure and fat loss. The method has been touted as a possible way to overcome the body’s natural resistance to losing weight and homeostasis.
The World Health Organization has approved a rapid test for ebola – the test can provide a result in just 15 minutes. The approval comes in the wake of the current ebola epidimic which has already claimed the lives of 9,300 people.
Research from Concordia has stated that a potential cure for cancer may already be present in the human body. A report published in the International Journal of Molecular Sciences has stated that lithocholic acid, a bile acid, is effective at killing cancer cells.
An analysis of 52 individual studies by the University of Oxford has found that the use of HRT (hormone replacement therapy) in women may increase the risk of ovarian cancer. HRT, as the name suggests, given to replace hormones that the body is no longer producing – in women, it is typically prescribed to post-menopausal women.
Researchers at Thomas Jefferson University have reported that a new type of treatment may be far more effective than current methods using current taxane family drugs. Prostate cancer is currently the second most common form of cancer amongst men in the United States. In the UK, over 40,000 new cases are identified each year so any improvement in treatment could have very positive effects for men all over the world.